Selected research
Market Outlook & Growth Opportunities
Global Oral Microbiome Products Market Outlook and Growth Opportunities 2026
Market perspective
The global Oral Microbiome Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Oral Microbiome Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oral Microbiome Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oral Microbiome Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Oral Microbiome Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Oral Microbiome Products market include Unilever PLC, Sunstar Suisse S.A., BioGaia AB, NatureWise, BLIS Technologies Ltd., Oral BioTech (Carifree), Vital Nutrients, Revitin Life Sciences and Procter & Gamble, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Oral Microbiome Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oral Microbiome Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oral Microbiome Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Microbiome Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Oral Microbiome Products Segment by Company
Unilever PLC
Sunstar Suisse S.A.
BioGaia AB
NatureWise
BLIS Technologies Ltd.
Oral BioTech (Carifree)
Vital Nutrients
Revitin Life Sciences
Procter & Gamble
Kenvue
Colgate-Palmolive
Dentaid
Johnson & Johnson
Reckitt Benckiser
Haleon
Church & Dwight
Lion Corporation
GC Corporation
Lallemand Inc.
ProBiora Health
DSM-Firmenich
Novonesis
BASF
Now Health Group, Inc.
GlaxoSmithKline
Hyperbiotics
Life Extension
Beneo Asia Pacific
Yili Group
Wecare Probiotics Co., Ltd.
Oral Microbiome Products Segment by Type
Oral Prebiotic
Microbiome Friendly Toothpaste
Microbiome Friendly Mouthwash
Others
Oral Microbiome Products Segment by Application
Retail Consumer
Dental Clinics and Hospitals
Health Stores
Others
Oral Microbiome Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Oral Microbiome Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Microbiome Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Microbiome Products significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Microbiome Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Microbiome Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Microbiome Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Microbiome Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Microbiome Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Microbiome Products industry.
Chapter 3: Detailed analysis of Oral Microbiome Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Microbiome Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Microbiome Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Prebiotic
- Microbiome Friendly Toothpaste
- Microbiome Friendly Mouthwash
- Others
Applications
- Retail Consumer
- Dental Clinics and Hospitals
- Health Stores
- Others
Companies covered
- Unilever PLC
- Sunstar Suisse S.A.
- BioGaia AB
- NatureWise
- BLIS Technologies Ltd.
- Oral BioTech (Carifree)
- Vital Nutrients
- Revitin Life Sciences
- Procter & Gamble
- Kenvue
- Colgate-Palmolive
- Dentaid
- Johnson & Johnson
- Reckitt Benckiser
- Haleon
- Church & Dwight
- Lion Corporation
- GC Corporation
- Lallemand Inc.
- ProBiora Health
- DSM-Firmenich
- Novonesis
- BASF
- Now Health Group, Inc.
- GlaxoSmithKline
- Hyperbiotics
- Life Extension
- Beneo Asia Pacific
- Yili Group
- Wecare Probiotics Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oral Microbiome Products Sales Value (2021-2032)
- 1.2.2 Global Oral Microbiome Products Sales Volume (2021-2032)
- 1.2.3 Global Oral Microbiome Products Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Oral Microbiome Products Market Dynamics
- 2.1 Oral Microbiome Products Industry Trends
- 2.2 Oral Microbiome Products Industry Drivers
- 2.3 Oral Microbiome Products Industry Opportunities and Challenges
- 2.4 Oral Microbiome Products Industry Restraints
3 Oral Microbiome Products Market by Company
- 3.1 Global Oral Microbiome Products Company Revenue Ranking in 2025
- 3.2 Global Oral Microbiome Products Revenue by Company (2021-2026)
- 3.3 Global Oral Microbiome Products Sales Volume by Company (2021-2026)
- 3.4 Global Oral Microbiome Products Average Price by Company (2021-2026)
- 3.5 Global Oral Microbiome Products Company Ranking (2024-2026)
- 3.6 Global Oral Microbiome Products Company Manufacturing Base and Headquarters
- 3.7 Global Oral Microbiome Products Company Product Type and Application
- 3.8 Global Oral Microbiome Products Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Oral Microbiome Products Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Oral Microbiome Products Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Oral Microbiome Products Market by Type
- 4.1 Oral Microbiome Products Type Introduction
- 4.1.1 Oral Prebiotic
- 4.1.2 Microbiome Friendly Toothpaste
- 4.1.3 Microbiome Friendly Mouthwash
- 4.1.4 Others
- 4.2 Global Oral Microbiome Products Sales Volume by Type
- 4.2.1 Global Oral Microbiome Products Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Oral Microbiome Products Sales Volume by Type (2021-2032)
- 4.2.3 Global Oral Microbiome Products Sales Volume Share by Type (2021-2032)
- 4.3 Global Oral Microbiome Products Sales Value by Type
- 4.3.1 Global Oral Microbiome Products Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Oral Microbiome Products Sales Value by Type (2021-2032)
- 4.3.3 Global Oral Microbiome Products Sales Value Share by Type (2021-2032)
5 Oral Microbiome Products Market by Application
- 5.1 Oral Microbiome Products Application Introduction
- 5.1.1 Retail Consumer
- 5.1.2 Dental Clinics and Hospitals
- 5.1.3 Health Stores
- 5.1.4 Others
- 5.2 Global Oral Microbiome Products Sales Volume by Application
- 5.2.1 Global Oral Microbiome Products Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Microbiome Products Sales Volume by Application (2021-2032)
- 5.2.3 Global Oral Microbiome Products Sales Volume Share by Application (2021-2032)
- 5.3 Global Oral Microbiome Products Sales Value by Application
- 5.3.1 Global Oral Microbiome Products Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Oral Microbiome Products Sales Value by Application (2021-2032)
- 5.3.3 Global Oral Microbiome Products Sales Value Share by Application (2021-2032)
6 Oral Microbiome Products Regional Sales and Value Analysis
- 6.1 Global Oral Microbiome Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Oral Microbiome Products Sales by Region (2021-2032)
- 6.2.1 Global Oral Microbiome Products Sales by Region: 2021-2026
- 6.2.2 Global Oral Microbiome Products Sales by Region (2027-2032)
- 6.3 Global Oral Microbiome Products Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Oral Microbiome Products Sales Value by Region (2021-2032)
- 6.4.1 Global Oral Microbiome Products Sales Value by Region: 2021-2026
- 6.4.2 Global Oral Microbiome Products Sales Value by Region (2027-2032)
- 6.5 Global Oral Microbiome Products Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Oral Microbiome Products Sales Value (2021-2032)
- 6.6.2 North America Oral Microbiome Products Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Oral Microbiome Products Sales Value (2021-2032)
- 6.7.2 Europe Oral Microbiome Products Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Oral Microbiome Products Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Oral Microbiome Products Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Oral Microbiome Products Sales Value (2021-2032)
- 6.9.2 South America Oral Microbiome Products Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Oral Microbiome Products Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Oral Microbiome Products Sales Value Share by Country, 2025 VS 2032
7 Oral Microbiome Products Country-level Sales and Value Analysis
- 7.1 Global Oral Microbiome Products Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Oral Microbiome Products Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Oral Microbiome Products Sales by Country (2021-2032)
- 7.3.1 Global Oral Microbiome Products Sales by Country (2021-2026)
- 7.3.2 Global Oral Microbiome Products Sales by Country (2027-2032)
- 7.4 Global Oral Microbiome Products Sales Value by Country (2021-2032)
- 7.4.1 Global Oral Microbiome Products Sales Value by Country (2021-2026)
- 7.4.2 Global Oral Microbiome Products Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.9.2 France Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.16.2 China Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.19.2 India Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Oral Microbiome Products Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Oral Microbiome Products Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Oral Microbiome Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Unilever PLC
- 8.1.1 Unilever PLC Company Information
- 8.1.2 Unilever PLC Business Overview
- 8.1.3 Unilever PLC Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Unilever PLC Oral Microbiome Products Product Portfolio
- 8.1.5 Unilever PLC Recent Developments
- 8.2 Sunstar Suisse S.A.
- 8.2.1 Sunstar Suisse S.A. Company Information
- 8.2.2 Sunstar Suisse S.A. Business Overview
- 8.2.3 Sunstar Suisse S.A. Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Sunstar Suisse S.A. Oral Microbiome Products Product Portfolio
- 8.2.5 Sunstar Suisse S.A. Recent Developments
- 8.3 BioGaia AB
- 8.3.1 BioGaia AB Company Information
- 8.3.2 BioGaia AB Business Overview
- 8.3.3 BioGaia AB Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.3.4 BioGaia AB Oral Microbiome Products Product Portfolio
- 8.3.5 BioGaia AB Recent Developments
- 8.4 NatureWise
- 8.4.1 NatureWise Company Information
- 8.4.2 NatureWise Business Overview
- 8.4.3 NatureWise Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.4.4 NatureWise Oral Microbiome Products Product Portfolio
- 8.4.5 NatureWise Recent Developments
- 8.5 BLIS Technologies Ltd.
- 8.5.1 BLIS Technologies Ltd. Company Information
- 8.5.2 BLIS Technologies Ltd. Business Overview
- 8.5.3 BLIS Technologies Ltd. Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.5.4 BLIS Technologies Ltd. Oral Microbiome Products Product Portfolio
- 8.5.5 BLIS Technologies Ltd. Recent Developments
- 8.6 Oral BioTech (Carifree)
- 8.6.1 Oral BioTech (Carifree) Company Information
- 8.6.2 Oral BioTech (Carifree) Business Overview
- 8.6.3 Oral BioTech (Carifree) Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Oral BioTech (Carifree) Oral Microbiome Products Product Portfolio
- 8.6.5 Oral BioTech (Carifree) Recent Developments
- 8.7 Vital Nutrients
- 8.7.1 Vital Nutrients Company Information
- 8.7.2 Vital Nutrients Business Overview
- 8.7.3 Vital Nutrients Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Vital Nutrients Oral Microbiome Products Product Portfolio
- 8.7.5 Vital Nutrients Recent Developments
- 8.8 Revitin Life Sciences
- 8.8.1 Revitin Life Sciences Company Information
- 8.8.2 Revitin Life Sciences Business Overview
- 8.8.3 Revitin Life Sciences Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Revitin Life Sciences Oral Microbiome Products Product Portfolio
- 8.8.5 Revitin Life Sciences Recent Developments
- 8.9 Procter & Gamble
- 8.9.1 Procter & Gamble Company Information
- 8.9.2 Procter & Gamble Business Overview
- 8.9.3 Procter & Gamble Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Procter & Gamble Oral Microbiome Products Product Portfolio
- 8.9.5 Procter & Gamble Recent Developments
- 8.10 Kenvue
- 8.10.1 Kenvue Company Information
- 8.10.2 Kenvue Business Overview
- 8.10.3 Kenvue Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Kenvue Oral Microbiome Products Product Portfolio
- 8.10.5 Kenvue Recent Developments
- 8.11 Colgate-Palmolive
- 8.11.1 Colgate-Palmolive Company Information
- 8.11.2 Colgate-Palmolive Business Overview
- 8.11.3 Colgate-Palmolive Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Colgate-Palmolive Oral Microbiome Products Product Portfolio
- 8.11.5 Colgate-Palmolive Recent Developments
- 8.12 Dentaid
- 8.12.1 Dentaid Company Information
- 8.12.2 Dentaid Business Overview
- 8.12.3 Dentaid Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Dentaid Oral Microbiome Products Product Portfolio
- 8.12.5 Dentaid Recent Developments
- 8.13 Johnson & Johnson
- 8.13.1 Johnson & Johnson Company Information
- 8.13.2 Johnson & Johnson Business Overview
- 8.13.3 Johnson & Johnson Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Johnson & Johnson Oral Microbiome Products Product Portfolio
- 8.13.5 Johnson & Johnson Recent Developments
- 8.14 Reckitt Benckiser
- 8.14.1 Reckitt Benckiser Company Information
- 8.14.2 Reckitt Benckiser Business Overview
- 8.14.3 Reckitt Benckiser Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Reckitt Benckiser Oral Microbiome Products Product Portfolio
- 8.14.5 Reckitt Benckiser Recent Developments
- 8.15 Haleon
- 8.15.1 Haleon Company Information
- 8.15.2 Haleon Business Overview
- 8.15.3 Haleon Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Haleon Oral Microbiome Products Product Portfolio
- 8.15.5 Haleon Recent Developments
- 8.16 Church & Dwight
- 8.16.1 Church & Dwight Company Information
- 8.16.2 Church & Dwight Business Overview
- 8.16.3 Church & Dwight Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Church & Dwight Oral Microbiome Products Product Portfolio
- 8.16.5 Church & Dwight Recent Developments
- 8.17 Lion Corporation
- 8.17.1 Lion Corporation Company Information
- 8.17.2 Lion Corporation Business Overview
- 8.17.3 Lion Corporation Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Lion Corporation Oral Microbiome Products Product Portfolio
- 8.17.5 Lion Corporation Recent Developments
- 8.18 GC Corporation
- 8.18.1 GC Corporation Company Information
- 8.18.2 GC Corporation Business Overview
- 8.18.3 GC Corporation Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.18.4 GC Corporation Oral Microbiome Products Product Portfolio
- 8.18.5 GC Corporation Recent Developments
- 8.19 Lallemand Inc.
- 8.19.1 Lallemand Inc. Company Information
- 8.19.2 Lallemand Inc. Business Overview
- 8.19.3 Lallemand Inc. Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Lallemand Inc. Oral Microbiome Products Product Portfolio
- 8.19.5 Lallemand Inc. Recent Developments
- 8.20 ProBiora Health
- 8.20.1 ProBiora Health Company Information
- 8.20.2 ProBiora Health Business Overview
- 8.20.3 ProBiora Health Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.20.4 ProBiora Health Oral Microbiome Products Product Portfolio
- 8.20.5 ProBiora Health Recent Developments
- 8.21 DSM-Firmenich
- 8.21.1 DSM-Firmenich Company Information
- 8.21.2 DSM-Firmenich Business Overview
- 8.21.3 DSM-Firmenich Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.21.4 DSM-Firmenich Oral Microbiome Products Product Portfolio
- 8.21.5 DSM-Firmenich Recent Developments
- 8.22 Novonesis
- 8.22.1 Novonesis Company Information
- 8.22.2 Novonesis Business Overview
- 8.22.3 Novonesis Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Novonesis Oral Microbiome Products Product Portfolio
- 8.22.5 Novonesis Recent Developments
- 8.23 BASF
- 8.23.1 BASF Company Information
- 8.23.2 BASF Business Overview
- 8.23.3 BASF Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.23.4 BASF Oral Microbiome Products Product Portfolio
- 8.23.5 BASF Recent Developments
- 8.24 Now Health Group, Inc.
- 8.24.1 Now Health Group, Inc. Company Information
- 8.24.2 Now Health Group, Inc. Business Overview
- 8.24.3 Now Health Group, Inc. Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Now Health Group, Inc. Oral Microbiome Products Product Portfolio
- 8.24.5 Now Health Group, Inc. Recent Developments
- 8.25 GlaxoSmithKline
- 8.25.1 GlaxoSmithKline Company Information
- 8.25.2 GlaxoSmithKline Business Overview
- 8.25.3 GlaxoSmithKline Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.25.4 GlaxoSmithKline Oral Microbiome Products Product Portfolio
- 8.25.5 GlaxoSmithKline Recent Developments
- 8.26 Hyperbiotics
- 8.26.1 Hyperbiotics Company Information
- 8.26.2 Hyperbiotics Business Overview
- 8.26.3 Hyperbiotics Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.26.4 Hyperbiotics Oral Microbiome Products Product Portfolio
- 8.26.5 Hyperbiotics Recent Developments
- 8.27 Life Extension
- 8.27.1 Life Extension Company Information
- 8.27.2 Life Extension Business Overview
- 8.27.3 Life Extension Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.27.4 Life Extension Oral Microbiome Products Product Portfolio
- 8.27.5 Life Extension Recent Developments
- 8.28 Beneo Asia Pacific
- 8.28.1 Beneo Asia Pacific Company Information
- 8.28.2 Beneo Asia Pacific Business Overview
- 8.28.3 Beneo Asia Pacific Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.28.4 Beneo Asia Pacific Oral Microbiome Products Product Portfolio
- 8.28.5 Beneo Asia Pacific Recent Developments
- 8.29 Yili Group
- 8.29.1 Yili Group Company Information
- 8.29.2 Yili Group Business Overview
- 8.29.3 Yili Group Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.29.4 Yili Group Oral Microbiome Products Product Portfolio
- 8.29.5 Yili Group Recent Developments
- 8.30 Wecare Probiotics Co., Ltd.
- 8.30.1 Wecare Probiotics Co., Ltd. Company Information
- 8.30.2 Wecare Probiotics Co., Ltd. Business Overview
- 8.30.3 Wecare Probiotics Co., Ltd. Oral Microbiome Products Sales, Value and Gross Margin (2021-2026)
- 8.30.4 Wecare Probiotics Co., Ltd. Oral Microbiome Products Product Portfolio
- 8.30.5 Wecare Probiotics Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Oral Microbiome Products Value Chain Analysis
- 9.1.1 Oral Microbiome Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oral Microbiome Products Sales Mode & Process
- 9.2 Oral Microbiome Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oral Microbiome Products Distributors
- 9.2.3 Oral Microbiome Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst